A study of nearly 90,000 US patients presented at the European Congress on Obesity found that people who lost 15% or more of their BMI while taking GLP-1 medications like Ozempic or Wegovy saw dramatically lower risks of obesity-r
← News
Medicine Breakthroughs Medicine Breakthroughs Health
People who lost the most weight on Ozempic saw huge health benefits
89,718 Patients studied
57.5 Years Average patient age
Ozempic, Wegovy, Mounjaro, Saxenda Medications tested
15%+ BMI Reduction Weight loss threshold
69% sleep apnea risk reduced
50% treatment discontinuation rate